Physician profile
Jonathan Alan Levine
NPI 1487673448
$5,703.25
in general payments reported to CMS, 2019-2025
8 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,200 · 2020: $3,026 · 2022: $145 · 2023: $68.59 · 2024: $79.63 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $4,650.51 | 2019-2020 | |
| Heraeus Medical Components, LLC | $450.00 | 2020 | |
| Medtronic, INC. | $210.25 | 2022-2025 | Ellipsys Vascular Access System, Inceptiv, Abre |
| Bard Peripheral Vascular, INC. | $166.94 | 2020-2022 | |
| Heron Therapeutics, INC. | $121.84 | 2025 | Zynrelef, Aponvie |
| Boston Scientific Corporation | $70.05 | 2022 | |
| Siemens Medical Solutions USA, INC. | $19.73 | 2024 | Cios Alpha |
| Medtronic USA, INC. | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.